17 - 21 June 2017
Helsinki, Finland

Industry Programme

Industry Key Opinion Leader Insights


Sunday, 18 June 2017


DBV Technologies
Pro & Con Arena
 
Investigational Epicutaneous Immunotherapy: Shaping the Future of Treating Food Allergies

Epicutaneous Immunotherapy (EPIT): A Brief Overview
Hugh A. Sampson, United States

Investigating EPIT in Milk‐Induced Eosinophilic Esophagitis
Jonathan M. Spergel, United States

Conclusions and Q&A